Valuation: Celltrion, Inc.

Market Cap 44,40800Cr 3.35TCr 2.99TCr 2.77TCr 2.51TCr 4.69TCr 3,18200Cr 4.77TCr 33TCr 13TCr 1,66700Cr 13TCr 12TCr 5,25600Cr P/E 2026 *
28.9x
P/E 2027 * 25.3x
Enterprise Value 4.6TCr 3.48Cr 3.1Cr 2.87Cr 2.6Cr 4.86Cr 329.96Cr 4.94Cr 35Cr 14Cr 172.88Cr 13Cr 13Cr 545.04Cr EV / Sales 2026 *
8.21x
EV / Sales 2027 * 7.15x
Free-Float
58.02%
Yield 2026 *
0.37%
Yield 2027 * 0.4%
1 day+0.05%
1 week+0.21%
Current month+9.40%
1 month+9.58%
3 months+9.46%
6 months-2.33%
Current year+12.77%
1 week 1,89,500
Extreme 189500
2,03,500
1 month 1,73,700
Extreme 173700
2,03,500
Current year 1,58,500
Extreme 158500
2,39,047.62
1 year 1,58,500
Extreme 158500
2,39,047.62
3 years 1,28,553.99
Extreme 128553.985695
2,39,047.62
5 years 1,14,250.83
Extreme 114250.828535
2,39,047.62
10 years 64,487.59
Extreme 64487.593381
3,25,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/01/26 Sell 500 0.0002%
16/01/26 Sell 1,000 0.0004%
16/01/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+0.21%+18.06%+48.50% 3.35TCr
+2.41%+0.29%+39.41%+72.14% 6.47TCr
-0.15%+7.50%+11.42%+71.27% 5.48TCr
+0.57%+4.60%+7.71%+90.93% 5.35TCr
+0.37%+4.67%+26.68%+49.64% 4.6TCr
-1.21%+2.32%+21.50%+118.33% 4.29TCr
-0.37%+5.07%+243.23%+789.58% 4.01TCr
+1.19%-4.98%+26.31%-0.76% 2.4TCr
-0.38%+5.68%+38.39%+28.35% 2.37TCr
-1.73%+0.46%-16.61%-8.02% 2.21TCr
Average +0.08%+2.22%+41.61%+126.00% 4.05TCr
Weighted average by Cap. +0.27%+2.61%+42.60%+134.60%

Financials

2026 *2027 *
Net sales 5,60600Cr 423.14Cr 377.86Cr 349.07Cr 316.34Cr 591.82Cr 40TCr 601.61Cr 4.2TCr 1.66TCr 21TCr 1.59TCr 1.55TCr 66TCr 6,38900Cr 482.27Cr 430.67Cr 397.85Cr 360.55Cr 674.53Cr 46TCr 685.69Cr 4.79TCr 1.9TCr 24TCr 1.81TCr 1.77TCr 76TCr
Net income 1,59000Cr 120.04Cr 107.2Cr 99Cr 90Cr 167.9Cr 11TCr 170.68Cr 1.19TCr 471.8Cr 5.97TCr 450.51Cr 440.93Cr 19TCr 1,77700Cr 134.17Cr 119.81Cr 110.69Cr 100.31Cr 187.66Cr 13TCr 190.76Cr 1.33TCr 527.33Cr 6.67TCr 503.53Cr 492.82Cr 21TCr
Net Debt 1,63900Cr 123.75Cr 110.51Cr 102.09Cr 93Cr 173.09Cr 12TCr 175.95Cr 1.23TCr 486.39Cr 6.16TCr 464.44Cr 454.56Cr 19TCr 1,27300Cr 96Cr 86Cr 79Cr 72Cr 134.38Cr 9.12TCr 136.61Cr 953.81Cr 377.62Cr 4.78TCr 360.58Cr 352.91Cr 15TCr
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
23/26/23 ₩1,94,400.00 +0.05% 4,54,998
22/26/22 ₩1,94,300.00 -1.67% 5,20,793
21/26/21 ₩1,97,600.00 +0.10% 6,01,867
20/26/20 ₩1,97,400.00 -0.40% 7,05,641
19/26/19 ₩1,98,200.00 +2.16% 7,01,654
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
1,94,400.00KRW
Average target price
2,69,303.03KRW
Spread / Average Target
+38.53%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock